本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bolt Biotherapeutics, Inc.

4.24
+0.13003.16%
成交量:2.87万
成交额:12.52万
市值:813.84万
市盈率:-0.26
高:4.68
开:4.13
低:4.13
收:4.11
52周最高:7.20
52周最低:3.10
股本:191.94万
流通股本:144.06万
量比:0.78
换手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-16.3353
每股收益(LYR):-17.8500
净资产收益率:-111.65%
总资产收益率:-30.73%
市净率:0.64
市盈率(LYR):-0.24

数据加载中...

2021/11/19

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

重要事件披露

8-K - Current report
2021/08/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/12

重要事件披露

8-K - Current report
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/02

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

重要事件披露

8-K - Current report
2021/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/11

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/09

重要事件披露

8-K - Current report
2021/02/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933